Literature DB >> 9923803

Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer.

M Kayahara1, T Nagakawa, T Ohta, H Kitagawa, H Tajima, K Miwa.   

Abstract

OBJECTIVE: To determine the pattern of middle (Bm) and distal (Bi) bile duct cancers in an attempt to optimize surgical treatment. SUMMARY BACKGROUND DATA: Lymph node involvement and neural plexus invasion are the prognostic factors most amenable to surgery in Bm and Bi disease. However, a detailed analysis of these factors has not been conducted.
METHODS: Fifty patients with Bm and Bi disease (Bm 14 patients, Bi 36 patients) were examined histopathologically. A precise determination was made of lymph node involvement and neural plexus invasion. Important prognostic factors were examined by clinicopathologic study to apply these findings to surgical management.
RESULTS: Frequencies of nodal involvement for Bm and Bi disease were 57% and 71%, respectively. The inferior periductal and superior pancreaticoduodenal lymph nodes were most commonly involved. Neural plexus invasion occurred in 20% of patients, particularly involving the plexus in the hepatoduodenal ligament and pancreatic head. Tumor was present at the surgical margin in 50% and 14% of patients with Bm and Bi disease, respectively. Five-year survival rates were 65% in the absence of nodal metastasis and 21% with nodal metastasis. A significant correlation existed between absence of tumor at the surgical margin and survival. A Cox proportional hazard model projected absence of tumor at the surgical margin, followed by nodal involvement, as the strongest prognostic variables.
CONCLUSIONS: Absence of tumor at the surgical margin and nodal involvement are important independent prognostic factors in Bm and Bi disease. Skeletonization of the hepatoduodenal ligament, including portal vein resection, is necessary for patients with Bm disease, and a wide nodal dissection is essential in all patients.

Entities:  

Mesh:

Year:  1999        PMID: 9923803      PMCID: PMC1191611          DOI: 10.1097/00000658-199901000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Therapeutic neurotomy on head of pancreas for relief of pain due to chronic pancreatitis; a new technical procedure and its results.

Authors:  H YOSHIOKA; T WAKABAYASHI
Journal:  AMA Arch Surg       Date:  1958-04

2.  Surgical approaches for unresectable primary carcinoma of the hepatic hilus.

Authors:  N J Lygidakis; M N van der Heyde; R J van Dongen; J G Kromhout; G N Tytgat; K Huibregtse
Journal:  Surg Gynecol Obstet       Date:  1988-02

3.  Radical block resection of hepatoduodenal ligament for carcinoma of the bile duct with double catheter bypass for portal circulation.

Authors:  H Mimura; H Kim; Y Ochiai; N Takakura; K Hamazaki; H Tsuge; K Sakagami; K Orita
Journal:  Surg Gynecol Obstet       Date:  1988-12

4.  Translateral retroperitoneal approach in radical surgery for pancreatic carcinoma.

Authors:  T Nagakawa; M Kurachi; K Konishi; I Miyazaki
Journal:  Jpn J Surg       Date:  1982

Review 5.  Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.

Authors:  F Michelassi; F Erroi; P J Dawson; A Pietrabissa; S Noda; M Handcock; G E Block
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

6.  Clinicopathologic studies on perineural invasion of bile duct carcinoma.

Authors:  M R Bhuiya; Y Nimura; J Kamiya; S Kondo; S Fukata; N Hayakawa; S Shionoya
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

7.  Endosonographic TNM staging of extrahepatic bile duct cancer: comparison with pathological staging.

Authors:  T L Tio; J Cheng; O B Wijers; P R Sars; G N Tytgat
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

8.  Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey.

Authors:  R Reding; J L Buard; G Lebeau; B Launois
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

9.  Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach.

Authors:  J C Langer; B Langer; B R Taylor; R Zeldin; B Cummings
Journal:  Surgery       Date:  1985-10       Impact factor: 3.982

10.  Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus.

Authors:  M Kayahara; T Nagakawa; I Konishi; K Ueno; T Ohta; I Miyazaki
Journal:  Int J Pancreatol       Date:  1991-10
View more
  34 in total

1.  Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter?

Authors:  Anthony T Ruys; Fiebo J W Ten Kate; Olivier R Busch; Marc R Engelbrecht; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2011-09-26       Impact factor: 3.647

2.  Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Hiroki Ohge; Taijiro Sueda
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

3.  Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.

Authors:  Hiroshi Itoh; Koji Nishijima; Yoshiyuki Kurosaka; Shigeru Takegawa; Masato Kiriyama; Shotaro Dohba; Yasuhiko Kojima; Yasuo Saitoh
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

4.  Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients.

Authors:  Yoshihiro Sakamoto; Kazuaki Shimada; Satoshi Nara; Minoru Esaki; Hidenori Ojima; Tsuyoshi Sano; Junji Yamamoto; Tomoo Kosuge
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

5.  Evaluation of positive ductal margins of biliary tract cancer in intraoperative histological examination.

Authors:  Junji Ueda; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Masato Yoshioka; Atsushi Hirakata; Youichi Kawano; Yoshiaki Mizuguchi; Tetsuya Shimizu; Tomohiro Kanda; Hideyuki Takata; Ryota Kondo; Eiji Uchida
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

6.  Is it possible to define early distal cholangiocarcinoma?

Authors:  Fumihiko Miura; Keiji Sano; Hodaka Amano; Naoyuki Toyota; Keita Wada; Takuo Tokairin; Fukuo Kondo; Koichi Hayano; Hisahiro Matsubara; Tadahiro Takada
Journal:  Langenbecks Arch Surg       Date:  2015-10-30       Impact factor: 3.445

7.  Carcinoma of the middle bile duct: is bile duct segmental resection appropriate?

Authors:  Hyung-Geun Lee; Sang-Hoon Lee; Dong-Do Yoo; Kwang-Yeol Paik; Jin-Seok Heo; Seong-Ho Choi; Dong-Wook Choi
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

8.  Technical Details of an Anterior Approach to the Superior Mesenteric Artery During Pancreaticoduodenectomy.

Authors:  Yosuke Inoue; Akio Saiura; Masayuki Tanaka; Masaru Matsumura; Yoshinori Takeda; Yoshihiro Mise; Takeaki Ishizawa; Yu Takahashi
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

9.  Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.

Authors:  Satoshi Kondo; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Masato Nagino; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Masakazu Yamamoto; Masato Kayahara; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Satoshi Hirano; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16

10.  Flowcharts for the management of biliary tract and ampullary carcinomas.

Authors:  Shuichi Miyakawa; Shin Ishihara; Tadahiro Takada; Masaru Miyazaki; Kazuhiro Tsukada; Masato Nagino; Satoshi Kondo; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.